Secondary alveolar proteinosis in cancer patients

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
S LadebC Cordonnier

Abstract

Pulmonary alveolar proteinosis (AP) is a rare cause of progressive respiratory failure in the normal host. It was first described by Rosen and coworkers in 1958 on the morphological basis of the accumulation of a PAS-positive material in the alveolar space. A couple of years later, AP was found to be unexpectedly associated with malignant diseases, especially with acute or chronic myeloid leukemias. These forms were called secondary AP in opposition to the primary forms observed in normal hosts. Probably because of its morphological definition and late diagnosis by means of histology or autopsy material, secondary AP has been considered to be life-threatening for a long time. However, recent observations show that AP can be diagnosed early in the course of the disease, especially through bronchoalveolar lavage, as long as the pathologist is aware of this possibility. Another point is that secondary AP can be reversible, both clinically and morphologically. This article summarizes the clinical features, morphological findings, and the main malignant diseases associated with secondary AP. We also comment on the hypotheses proposed in the literature to explain the association of AP, malignant disease, and immunosuppression. Alveol...Continue Reading

References

Sep 1, 1976·Annals of Internal Medicine·D W GoldeM J Cline
Jan 30, 1975·The New England Journal of Medicine·J J RinehartA F LoBuglio
Jan 1, 1991·Toxicologic Pathology·G E Hook
Jan 1, 1991·The American Review of Respiratory Disease·R M Hoffman, R M Rogers
Jan 1, 1991·Annual Review of Physiology·J R Wright, L G Dobbs
Jun 1, 1987·Mayo Clinic Proceedings·U B PrakashH M Marsh
Jan 1, 1969·British Journal of Diseases of the Chest·J M Davidson, W M Macleod
Oct 1, 1968·The American Journal of Medicine·J Ramirez, W R Harlan
Feb 1, 1967·Archives of Internal Medicine·J Ramirez
May 1, 1982·International Journal of Radiation Oncology, Biology, Physics·D L ShapiroP Rubin
Sep 1, 1981·Critical Reviews in Toxicology·T Akino, K Ohno
Dec 3, 1981·The New England Journal of Medicine·K TejaP T Schnatterly
Nov 1, 1980·The American Journal of Medicine·J R WebsterB Shapiro
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·C CordonnierJ F Bernaudin
Jun 5, 1958·The New England Journal of Medicine·S H ROSENA A LIEBOW
Jun 1, 1960·Annals of Internal Medicine·W R EDMONDSON, J B GERE

❮ Previous
Next ❯

Citations

Jul 14, 2010·Journal of General Internal Medicine·Shiwan K ShahGulshan Sharma
Dec 26, 2003·The New England Journal of Medicine·Bruce C TrapnellKoh Nakata
Oct 16, 2013·The Journal of Experimental Medicine·Atsushi NakamuraKazuhiko Igarashi
Oct 23, 2010·Current Opinion in Allergy and Clinical Immunology·Sarah K Browne, Steven M Holland
Sep 3, 2011·Pathology International·Michiya NishinoRichard L Kradin
Aug 19, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Noel R WardwellLorraine B Ware
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine·M S CarrawayC A Piantadosi
Feb 17, 2001·American Journal of Respiratory and Critical Care Medicine·J F SeymourA R Dunn
Jul 18, 2002·American Journal of Respiratory and Critical Care Medicine·John F Seymour, Jeffrey J Presneill
Oct 22, 2008·American Journal of Respiratory Cell and Molecular Biology·Masataka ShibasakiTsutomu Kawabe
Jun 10, 2010·Lung India : Official Organ of Indian Chest Society·Gurcharan Singh Thind
Feb 7, 2014·Annual Review of Immunology·Sarah K Browne
Nov 5, 2011·Journal of Clinical Anesthesia·Fahd AlgurashiHelmut Unruh
Mar 27, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Brenna Carey, Bruce C Trapnell
Jan 15, 2005·Pathology, Research and Practice·Marie-Rose Akin, Gia-Khanh Nguyen
Aug 28, 2004·Clinics in Chest Medicine·Jeffrey J PresneillJohn F Seymour
Nov 27, 2010·The Lancet Infectious Diseases·Sarah K Browne, Steven M Holland
Oct 11, 2014·Hematology/oncology and Stem Cell Therapy·Chakra P ChaulagainJohn K Erban
Mar 22, 2001·Australasian Radiology·J Stahl, M R Sage
Jul 2, 2019·Current Opinion in Pulmonary Medicine·Cormac McCarthyFrancesco Bonella
Nov 5, 2008·Journal of the American Animal Hospital Association·Sandrine DehardCecile Clercx
Aug 1, 2019·Current Opinion in Pulmonary Medicine·Cormac McCarthyFrancesco Bonella
Feb 3, 2004·Critical Reviews in Computed Tomography·Maureen R Horton
Aug 19, 2006·Chronic Respiratory Disease·O C Ioachimescu, M S Kavuru
Mar 9, 2019·Nature Reviews. Disease Primers·Bruce C TrapnellCormac McCarthy
Mar 18, 2020·Genes & Diseases·Ankita SinghAmit Rawat
Aug 20, 2021·Therapeutics and Clinical Risk Management·Hira IftikharAnupam Kumar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.